TLPH FY 2020 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$5M+136.6% YoY

Gross Profit

-$616,000-11.4% margin

Operating Income

-$41M-756.3% margin

Net Income

-$40M-745.6% margin

EPS (Diluted)

$-9.47

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$40M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$66M

Total Liabilities

$122M

Stockholders' Equity

-$56M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$2M	+136.6%
Gross Profit	-$616,000	-$5M	+86.4%
Operating Income	-$41M	-$54M	+24.4%
Net Income	-$40M	-$53M	+24.2%